There are now 9 novel medical products under development at VIC targeting specific cancers, infectious and immune mediated diseases including mesothelioma, Q fever and type 1 diabetes. These products are broadly applicable and include devices, cell therapies and the repurposing of immunomodulatory small molecules and the invention of biologics.
- Innovative translational bench to bedside science team
- Training and career development for next generation of translational scientists
- Distributed development with best in class collaborators
- Assiduous project management and product development
- Position projects for effective translational hand-off, including foundation for regulatory review
- Diversified funding portfolio
